Cytochrome P450 (CYP) is a gene superfamily of hemoproteins that catalyze the oxidation of lipophilic substrates to more water-soluble products. Among them, the human CYP3A subfamily contains mainly three isoforms, CYP3A4, CYP3A5, and CYP3A7. 1) CYP3A4 is the predominant isoform expressed in adult human liver and intestine, 2, 3) and plays a significant role in the metabolism of endogenous and exogenous compounds. 4) CYP3A5 is expressed polymorphically throughout development in the liver.
Unlike the fetal liver in most experimental animals, the human fetus supports the oxidative metabolism of a wide range of drugs and other xenobiotics. 11) Toxicological and pharmacological studies designed to assess the safety and efficacy of candidate drugs and chemicals in the human fetus depend greatly on extrapolation from animal models. However, it has been difficult to estimate alterations of drug metabolism by inducers of drug-metabolizing enzymes in the human fetus due to the problem of differences among species.
12) Species differences in the inducibility of drug-metabolizing enzymes 13, 14) result in important differences in the metabolism of drugs and potential carcinogens. The induction of CYP3A in human-derived cell lines has been studied as a model of human tissues. 15) As research with human subjects, especially when pregnant, should be restricted due to ethical considerations, human fetal in vitro models have been evaluated with increasing frequency to find those that are most suitable for predicting human responses in vivo.
The HepG2 cell line was established from a liver tumor biopsy specimen from a 15-year-old Caucasian male subject. 16) This cell line has features of hepatoblast-like cells, because the cells express CYP3A7 17) and secrete a-fetoprotein (AFP) 16) into the cell culture medium, both proteins that are found predominantly in human fetal hepatocytes. 7) However, it is unknown whether HepG2 is a useful cell line as a human fetal liver (HFL) model for experiments regarding drug metabolism, because there have been no comparisons of gene expression between HFL and HepG2 cells, and limited data are available regarding comparison of the responses of HepG2 and HFL cells to inducers.
In the present study, to characterize the expression and induction of CYP in HFL cells, the basal gene expression patterns and inducibility of CYP, especially CYP3A isoforms, were compared to those in HepG2 cells.
MATERIALS AND METHODS

Chemicals
Dulbecco's phosphate-buffered saline (PBS) was from Dainippon Pharmaceutical Co. (Osaka, Japan). Dulbecco's modified Eagle's medium and Williams' medium E were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). Penicillin-streptomycin-neomycin antibiotic mixture and SuperScript First-Strand Synthesis System for reverse transcription-polymerase chain reaction (RT-PCR) were from Invitrogen Corp. (Carlsbad, CA, U.S.A.). DEX, RIF, dimethyl sulfoxide (DMSO), Cell Banker, ISOGEN, and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) were from Wako Pure Chemicals (Osaka, Japan). Collagen (type I) was from Koken (Tokyo, Japan). PCR primers were purchased from Sigma Genosys (Hokkaido, Japan). All other reagents used were of the highest quality available.
Cells HFL cells were obtained from Applied Cell Biology Research Institute (Kirkland, WA, U.S.A.). The cell culture was initiated from a pool of six normal human liver tissues (average 13 weeks of gestation) by elutriation following dispase digestion of tissue. The cells were subcultured when the culture reached 90-100% confluence, and suspended in Cell Banker after proliferation. Aliquots of the suspensions were cryopreserved at Ϫ150°C until use. HepG2 cells were obtained from Cell Resource Center for Biomedical Research, Tohoku University, Japan.
Evaluation of Cell Proliferation by MTT Assay
The HFL cells at passage numbers 2, 6, and 10 cryopreserved at Ϫ150°C were used for evaluation of cell proliferation. Proliferation of the cells was evaluated using the MTT assay as described previously.
18) The MTT-derived blue formazan product formed in viable cells was dissolved with DMSO and quantified by determining its absorbance at 570 nm.
Cell Culture and Drug Treatment HepG2 cells and HFL cells (passage number 1 or 4) were seeded onto dishes coated with type I collagen and cultured in Dulbecco's modified Eagle's medium and Williams' medium E, respectively, supplemented with 10% (v/v) fetal bovine serum, 2 mM glutamine, and antibiotics (50 mg/ml penicillin, 50 mg/ml streptomycin, and 100 mg/ml neomycin) under an atmosphere of 5% CO 2 in air at 37°C. The medium was exchanged every 24 h. In the drug-treatment groups, HepG2 and HFL cells were cultured for 7 or 17 d after seeding of 1ϫ10 4 cells onto f3.5 cm culture plates, and then treated with DEX (100 mM) or RIF (40 mM) for 72 h. The above compounds were dissolved in DMSO, which was added to the culture medium at a final concentration of 0.1%. The medium was replaced daily with fresh medium containing either the test compounds dissolved in vehicle or vehicle alone.
RNA Extraction and Semi-quantitative RT-PCR Analysis Total RNA was extracted from the cells treated with ISOGEN. First-strand cDNA was generated from 2 mg of total RNA. Reverse transcription reaction was performed using a SuperScript First-Strand Synthesis System for RT-PCR in accordance with the manufacturer's instructions. With the cDNA obtained, PCR was carried out using a MyCycler thermal cycler (Bio-Rad, Hercules, CA, U.S.A.) and PCR Express thermal cycler (Hybaid Ltd., Teddington, Middlesex, U.K.). The primers and amplification conditions used are summarized in Table 1 . The levels of these mRNAs were quantified from their band densities on agarose gels using Printgraph AE-6914 and Scion Image Software (by Dr. W. Rasband), and were normalized relative to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA.
Statistical Analysis Statistical comparisons were performed with Student's t-test.
RESULTS
Influence of Passage on Cell Proliferation
First, the influence of passage on cell proliferation was examined in HFL cells. Proliferation and viability of the cells were evaluated using MTT assay as described in Materials and Methods. Cells at passage numbers 2, 6, and 10 were seeded onto collagen-coated culture dishes. The MTT-derived blue formazan product formed in viable cells increased by more than 100-fold for the first 15 d in culture, and then reached a plateau ( Fig. 1 ). There was no marked difference in the rate of proliferation among the cells, although cells at passage number 6 showed somewhat slower proliferation than those at passage 2 and 10.
Morphology of HepG2 and HFL Cells To highlight the morphological differences between HepG2 and HFL cells, micrographs of both cell lines are shown in Fig. 2 . At low plating density, many of the individual HFL and HepG2 cells exhibited epithelial-like morphological features (Fig. 2) . HFL cells uniformly proliferated on plates until reaching 100% confluence and formed a flattened monolayer. In early culture of HFL cells, the cells were predominantly small hepatocytic cells with a granular cytoplasm and a centrally placed nucleus. The main morphological features of these cells were homogeneous, and the cells were closely attached to each other forming a continuous monolayer. On the other hand, HepG2 cells overlapped each even at low cell density and formed colonies, because the cells did not exhibit uniform proliferation. Many of the HepG2 cells maintained a polygonal shape culture conditions even after overlapping with each other in the colonies. HFL cells did not exhibit contact inhibition of growth despite being normal cells (Fig.  2) . HFL cells achieved a higher saturation density at confluence, and displayed reduced adhesion and enhanced emigra- tion from confluent cell layers. Finally, not only HepG2 cells but also HFL cells overlapped each other and formed clusters on prolonged culture.
Time-Dependent Changes of Gene Expression Profiles in HepG2 and HFL Cells
The levels of expression of several hepatic proteins were very low in cultured hepatocytes, so we performed RT-PCR to detect the gene products (Fig.  3) . The expression levels and patterns of CYPs, albumin (ALB), AFP, and hepatocyte nuclear factor 4a (HNF4a) mRNAs in HFL cells were compared with those in HepG2 cells. In HFL cells, the expression levels of CYP3A4, CYP3A5, ALB, HNF4a, and hepatocyte growth factor (HGF) mRNAs increased gradually, while the expression level of AFP mRNA, which was expressed selectively in immature hepatocytes 19, 20) decreased gradually. Interestingly, the expression level of CYP3A7 mRNA was decreased after reaching a peak at 8 d in culture and increased again after 16 d in culture. On the other hand, the levels of CYP3A4, CYP3A5, and CYP3A7 mRNA expression in HepG2 cells decreased gradually. Furthermore, the expression levels of ALB and AFP mRNAs in HepG2 cells were determined at 2 d in culture and the expression levels of both mRNAs were not changed during the culture period. The expression of HGF mRNA was not detected in HepG2 cells.
Basal Expression and Induction by DEX of CYPs in HepG2 and HFL Cells HepG2 cells showed mRNA expression of major CYP isoforms related to drug metabolism in the human liver, i.e., CYP1A2, CYP2A6, CYP2B6, CYP2C (2C9 and 2C19), CYP2D6, CYP2E1, CYP3A4, CYP3A5, and CYP3A7 (Fig. 4) . With the exception of CYP1A2, all of the CYP mRNAs expressed in HepG2 cells were also detected in HFL cells. The levels of expression of CYP2A6, CYP2B6, CYP2D6, CYP2E1, CYP3A4, CYP3A5, and CYP3A7 mRNAs in HFL cells were increased by DEX. However, with the exception of CYP3A4 and CYP3A7, DEX did not induce expression of these CYPs in HepG2 cells. Especially, CYP2B6 mRNA expression was decreased after treatment with DEX. The expression of HGF mRNA was detected only in HFL cells and was markedly suppressed by DEX. The mRNA expression of HNF4a, which is important for pregnane X receptor (PXR)-mediated induction of CYP3A4 by xenobiotics, 21) was expressed in both cell lines. Effects of Inducers on CYP3As mRNA Expression in HepG2 and HFL Cells The effects of inducers on the expression of CYP3A4, CYP3A5, and CYP3A7 mRNAs in HFL cells are shown in Fig. 5 . The expression levels of CYP3A4, CYP3A5, and CYP3A7 mRNAs in HFL cells were significantly increased to 15-, 3-, and 18-fold, respectively, greater than control by DEX. However, RIF, which is highly effective inducer of CYP3A enzymes in adult human liver cells in primary culture, 9) did not appreciably induce expression of CYP3A4 and CYP3A7 mRNAs in HFL cells. On the other hand, the levels of CYP3A4, CYP3A5, and CYP3A7 mRNA expression in HepG2 cells were increased from 1.3-to 3-fold by treatment with DEX and RIF (Fig. 5) .
Expression of PXR and GRa a in HepG2 and HFL Cells RT-PCR was used to analyze expression of PXR and GRa in
HepG2 and HFL cells (Fig. 6) . PXR mRNA was expressed in HepG2 cells, but not HFL cells. GRa was detected in HepG2 cells and HFL cells. lism induced by candidate drugs and chemicals in humans due to species-related differences, although this has been researched extensively in experimental animals. 12) Primary cultures of human hepatocytes 22, 23) have been used extensively for evaluation of induction of drug-metabolizing enzymes in humans. Thus, primary cultures of hepatocytes are among the most useful cell lines as human liver models. Our previous study, however, suggested that the induction mechanisms of CYP3As in HFL may be different from those in the adult liver. 24) Therefore, experiments using HFL cells need to estimate the effects of drugs on human fetal drug-metabolizing enzymes, as research in pregnant human subjects should be restricted due to ethical considerations. On the other hand, HepG2 cells that express fetal-specific proteins, such as CYP3A7 7) and AFP, 20) have been used in a number of studies of drug metabolism. 15, 25) However, there have been no comparative studies of gene expression between HepG2 cells and cultured HFL cells, and only limited data are available regarding the comparative cellular responses of these two systems to inducers. The present study was performed to further characterize the utility of HFL cells as an in vitro system in which to assess the effects of drugs and chemicals on CYP expression in the fetal liver.
In general, the maintenance of highly differentiated primary hepatocyte cultures, such as adult liver cells, has many limitations and difficulties. Typically, these cells rapidly lose differentiated phenotypic traits, and have a low replication capacity and features that prevent long-term maintenance and subculture. It was demonstrated that HFL cells have extremely high proliferative ability (Fig. 1) . Recently, Lazaro et al. 26) reported that HFL cells can be kept in primary culture for 2 to 4 months without apparent loss of hepatocytic traits in serum-free medium in the presence of epidermal growth factor and can be subcultured at least twice. We found that HFL cells can be subcultured at least 10 times without apparent loss of proliferative activity despite cryopreservation once at Ϫ150°C. The plating efficiency was high through experiments when HFL cells were cryopreserved as suspen- sions in Cell Banker. These results suggested that the HFL cells could be serially passaged and stored at Ϫ150°C until use.
The morphological characteristics and epithelial cell shape of HepG2 cells are compatible with those of liver parenchymal cells. 16) However, there were significant morphological differences between HepG2 and HFL cells. HepG2 cells formed clusters before reaching 100% confluence, while HFL cells proliferated uniformly on the plates and formed flattened monolayers.
Leeder et al. 27) reported that CYP3A7 is the most abundant CYP3A mRNA species present in 54 livers samples 76 d to 32 weeks estimated gestational age, and that the expression levels of CYP3A5 and CYP3A4 mRNAs are 100-and 1000-fold lower than CYP3A7 expression, respectively. We found that HFL cells constitutively express not only fetal CYP3A isoforms, CYP3A7 and CYP3A5, but also the adult isoform, CYP3A4. In general, the function of hepatocytes in primary culture decreased in a manner dependent on number of days in culture. 28) Especially, CYP3A4 level in primary hepatocytes isolated from adult humans was decreased markedly by incubation for several days. 29) In the present study, the expression levels of CYP3As in HFL cells increased gradually along with ALB by cultivation for 20 d, although CYP3A7 mRNA expression showed an initial increase, followed by a decrease, and a later increase (Fig. 3) . On the other hand, the expression level of AFP decreased gradually during culture. AFP and ALB have frequently served as model genes for developmentally regulated gene expression of the hepatic cell lineage. 30, 31) Among the secretory liver proteins, AFP is expressed already in early hepatoblasts and its expression levels increase throughout fetal development. After birth, the AFP gene is selectively silenced. 19, 20) In contrast, expression of ALB, the most abundant serum protein synthesized by hepatocytes, begins in early fetal hepatocytes and reaches the maximal level in adult hepatocytes. 32) These results suggest that HFL cells containing immature hepatocytes differentiate into more mature cells during culture. On the other hand, the expression of these mRNAs in HepG2 cells did not change appreciably during culture. These results indicate that the character of HepG2 cells is different from that of HFL cells.
HepG2 cells are deficient in the expression of many CYPs 33) that would provide a basis for differential responses to chemical exposure. Schuetz et al. 17) reported that HepG2 cells contained only CYP3A7 protein even after treatment with inducers, such as DEX and RIF. Ogino et al. 34) also reported that CYP3A4 is scarcely expressed and not enhanced by treatment with RIF despite the presence of PXR in this cell line. However, CYP1A2, CYP2A6, CYP2B6, CYP2C (2C9 and 2C19), CYP2D6, CYP2E1, CYP3A4, CYP3A5, and CYP3A7 mRNAs were detected in HepG2 cells by semiquantitative RT-PCR (Fig. 4) . Furthermore, we found that CYP3A mRNA expression was also enhanced by RIF together with DEX (Fig. 5) . These results were consistent with those reported previously by Sumida et al. 25) and Usui et al. 35) Hewitt and Hewitt 36) reported that HepG2 cells have phase I enzymes, i.e., CYP1A, CYP2C9, CYP2D6, CYP2B6, CYP2E1, and CYP3A, but their activities and levels are dependent on the source and culture conditions. This discrepancy may have been due to differences in source and/or culture conditions. HNF4a is an important transcription factor regulating basal and PXR-mediated CYP3A4 promoter activation. 21) PXR mRNA was not detectable in HFL cells, although it was expressed in HepG2 cells. On the other hand, HNF4a mRNA was detected in HepG2 and HFL cells. PXR has been identified as the major receptor responsible for transcriptional activation of CYP3A gene expression. 37) Another cellular factor, GRa, 38, 39) is known to influence xenobiotic-mediated transcription induction, through cooperative activation of PXR expression. Expression level of GRa mRNA was almost identical in HepG2 and HFL cells. One reason why CYP3A4 and CYP3A7 mRNA expression were not induced by RIF in HFL cells may be that PXR expression level is very low in these cells as compared with HepG2 cells. On the other hand, these CYP enzymes in HFL cells were induced significantly by DEX. These results suggest that PXR is not an essential factor for basal expression and induction of CYP3A enzymes by DEX in HFL cells.
There are some reports about the expression of CYP enzymes and activity of drug-metabolizing enzymes in HFL. 27, [40] [41] [42] However, little is known concerning the induction of drug-metabolizing enzymes in HFL, because research with pregnant or fetus should be never attempted due to ethical considerations. The induction of CYP in HepG2 cells has been studied as a model of human liver. 15, 25) In the present study, however, it was demonstrated that character of HepG2 cells with regard to CYP expression was different from that of HFL cells, although HepG2 cell lives has features of hepatoblast-like cells. 16, 17) The maintenance of HFL cells is easier than that of the adult liver cells as described above. These results indicated that HFL cells might be most suitable as an in vitro system in which to assess the effects of drugs and chemicals on CYP expression in the fetal liver.
